{"transactions":[{"id":4622037,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Stock Options (Right to buy)","published_at":"2026-09-17T22:15:10.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Son"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on September 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's son's continuous service with the Issuer at each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents a stock option granted to the Reporting Person's son in connection with the commencement of his employment with the Issuer. The Reporting Person disclaims beneficial ownership of all securities held by her son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1000,"derivative":{"exercise_price":12.34,"expiration_date":"2036-09-15","underlying":"Common Shares","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001704186-26-000006","document":"wk-form4_1789683308.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170418626000006/wk-form4_1789683308.xml","form_type":"4"}},{"id":797085,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:09:42.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001850520-26-000005","document":"wk-form4_1777594180.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000185052026000005/wk-form4_1777594180.xml","form_type":"4"}},{"id":797087,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:09:11.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001329505-26-000005","document":"wk-form4_1777594149.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000132950526000005/wk-form4_1777594149.xml","form_type":"4"}},{"id":797084,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":37240,"kind":"person","name":"Heffernan Michael Thomas","position":1,"cik":"0001448914","reported_name":"Heffernan Michael Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:08:50.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001448914-26-000002","document":"wk-form4_1777594127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000144891426000002/wk-form4_1777594127.xml","form_type":"4"}},{"id":797083,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:08:04.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001926476-26-000002","document":"wk-form4_1777594081.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000192647626000002/wk-form4_1777594081.xml","form_type":"4"}},{"id":797218,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:07:52.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001027035-26-000008","document":"wk-form4_1777594070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000102703526000008/wk-form4_1777594070.xml","form_type":"4"}},{"id":797082,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:07:35.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001232505-26-000003","document":"wk-form4_1777594053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000123250526000003/wk-form4_1777594053.xml","form_type":"4"}},{"id":797081,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":46857,"kind":"person","name":"GREGORY JULIA P","position":1,"cik":"0001226675","reported_name":"GREGORY JULIA P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-05-01T00:06:40.000Z","date":"2026-04-28","kind":"grant","planned":false,"acquired":true,"shares":68693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":68693,"derivative":{"exercise_price":9.61,"expiration_date":"2036-04-28","underlying":"Common Shares","underlying_shares":68693},"source":{"system":"sec-edgar","filing":"0001226675-26-000002","document":"wk-form4_1777593998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000122667526000002/wk-form4_1777593998.xml","form_type":"4"}},{"id":833674,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-03-19T22:17:49.000Z","date":"2026-03-17","kind":"gift","planned":false,"acquired":true,"shares":17342,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Kishen Mehta 21 Family Irrevocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse and the spouse's sibling are co-trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":17342,"source":{"system":"sec-edgar","filing":"0001850520-26-000003","document":"wk-form4_1773958666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000185052026000003/wk-form4_1773958666.xml","form_type":"4"}},{"id":833673,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-03-19T22:17:49.000Z","date":"2026-03-17","kind":"gift","planned":false,"acquired":false,"shares":17342,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5320,"source":{"system":"sec-edgar","filing":"0001850520-26-000003","document":"wk-form4_1773958666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000185052026000003/wk-form4_1773958666.xml","form_type":"4"}},{"id":854430,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-03-09T22:12:05.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":28400,"price":30.4266,"value":864115.44,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on March 5, 2025 (the \"Original Form 4\"). The Original Form 4 inadvertently misstated that 3,400 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and 25,000 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 28,400 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust, and no Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2323971,"source":{"system":"sec-edgar","filing":"0001027035-26-000006","document":"wk-form4a_1773094322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000102703526000006/wk-form4a_1773094322.xml","form_type":"4/A","original_submission_date":"2025-03-05"}},{"id":868359,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Stock Options (Right to buy)","published_at":"2026-03-03T23:08:17.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":11.52,"expiration_date":"2036-02-27","underlying":"Common Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001704186-26-000004","document":"wk-form4_1772579294.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170418626000004/wk-form4_1772579294.xml","form_type":"4"}},{"id":868358,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-03-03T23:08:04.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":11.52,"expiration_date":"2036-02-27","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001878290-26-000004","document":"wk-form4_1772579282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000187829026000004/wk-form4_1772579282.xml","form_type":"4"}},{"id":868357,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-03-03T23:07:42.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":11.52,"expiration_date":"2036-02-27","underlying":"Common Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001798876-26-000004","document":"wk-form4_1772579259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000004/wk-form4_1772579259.xml","form_type":"4"}},{"id":868355,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-03-03T23:04:29.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":550000,"derivative":{"exercise_price":11.52,"expiration_date":"2036-02-27","underlying":"Common Shares","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001704317-26-000004","document":"wk-form4_1772579067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000004/wk-form4_1772579067.xml","form_type":"4"}},{"id":871065,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-03-03T18:09:03.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":11.52,"expiration_date":"2036-02-27","underlying":"Common Shares","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001898799-26-000004","document":"wk-form4_1772579341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000189879926000004/wk-form4_1772579341.xml","form_type":"4"}},{"id":944798,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Restricted Share Unit Award","published_at":"2026-01-08T02:34:08.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted 15,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":7500,"derivative":{"underlying":"Common Shares","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001704186-26-000002","document":"wk-form4_1767839645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170418626000002/wk-form4_1767839645.xml","form_type":"4"}},{"id":944797,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Common Shares","published_at":"2026-01-08T02:34:08.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1956,"price":9.93,"value":19423.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":99557,"source":{"system":"sec-edgar","filing":"0001704186-26-000002","document":"wk-form4_1767839645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170418626000002/wk-form4_1767839645.xml","form_type":"4"}},{"id":944796,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Common Shares","published_at":"2026-01-08T02:34:08.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":101513,"source":{"system":"sec-edgar","filing":"0001704186-26-000002","document":"wk-form4_1767839645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170418626000002/wk-form4_1767839645.xml","form_type":"4"}},{"id":944792,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit Award","published_at":"2026-01-08T02:32:31.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":28500,"derivative":{"underlying":"Common Shares","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001704317-26-000002","document":"wk-form4_1767839548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000002/wk-form4_1767839548.xml","form_type":"4"}},{"id":944791,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:31.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":7430,"price":9.93,"value":73779.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":1803968,"source":{"system":"sec-edgar","filing":"0001704317-26-000002","document":"wk-form4_1767839548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000002/wk-form4_1767839548.xml","form_type":"4"}},{"id":944790,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:31.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1811398,"source":{"system":"sec-edgar","filing":"0001704317-26-000002","document":"wk-form4_1767839548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000002/wk-form4_1767839548.xml","form_type":"4"}},{"id":944795,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Share Unit Award","published_at":"2026-01-08T02:32:04.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":9500,"derivative":{"underlying":"Common Shares","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001798876-26-000002","document":"wk-form4_1767839521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000002/wk-form4_1767839521.xml","form_type":"4"}},{"id":944794,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:04.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2381,"price":9.93,"value":23643.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025."}],"balance_after":7715,"source":{"system":"sec-edgar","filing":"0001798876-26-000002","document":"wk-form4_1767839521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000002/wk-form4_1767839521.xml","form_type":"4"}},{"id":944793,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:04.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025."}],"balance_after":10096,"source":{"system":"sec-edgar","filing":"0001798876-26-000002","document":"wk-form4_1767839521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000179887626000002/wk-form4_1767839521.xml","form_type":"4"}},{"id":944789,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Share Unit Award","published_at":"2026-01-08T02:31:18.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person was granted 10,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":5000,"derivative":{"underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001878290-26-000002","document":"wk-form4_1767839475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000187829026000002/wk-form4_1767839475.xml","form_type":"4"}},{"id":944788,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:31:18.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1117,"price":9.93,"value":11091.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":66978,"source":{"system":"sec-edgar","filing":"0001878290-26-000002","document":"wk-form4_1767839475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000187829026000002/wk-form4_1767839475.xml","form_type":"4"}},{"id":944787,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:31:18.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68095,"source":{"system":"sec-edgar","filing":"0001878290-26-000002","document":"wk-form4_1767839475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000187829026000002/wk-form4_1767839475.xml","form_type":"4"}},{"id":945224,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Unit Award","published_at":"2026-01-07T21:33:22.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":8500,"derivative":{"underlying":"Common Shares","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001898799-26-000002","document":"wk-form4_1767839598.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000189879926000002/wk-form4_1767839598.xml","form_type":"4"}},{"id":945223,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-07T21:33:22.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2594,"price":9.93,"value":25758.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025."}],"balance_after":195652,"source":{"system":"sec-edgar","filing":"0001898799-26-000002","document":"wk-form4_1767839598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000189879926000002/wk-form4_1767839598.xml","form_type":"4"}},{"id":945222,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-07T21:33:22.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 544 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2025."}],"balance_after":198246,"source":{"system":"sec-edgar","filing":"0001898799-26-000002","document":"wk-form4_1767839598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000189879926000002/wk-form4_1767839598.xml","form_type":"4"}},{"id":996027,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-11-18T12:29:10.000Z","date":"2025-11-17","kind":"purchase","planned":false,"acquired":true,"shares":17000,"price":8.5159,"value":144770.3,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4950 - $8.5200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001878290-25-000004","document":"wk-form4_1763468947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000187829025000004/wk-form4_1763468947.xml","form_type":"4"}},{"id":997978,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-17T12:31:22.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":7.5,"value":3000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":2020071,"source":{"system":"sec-edgar","filing":"0001935979-25-000096","document":"wk-form4_1763382679.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000096/wk-form4_1763382679.xml","form_type":"4"}},{"id":998182,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-17T12:30:45.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":3333333,"price":7.5,"value":24999997.5,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":5653904,"source":{"system":"sec-edgar","filing":"0001027035-25-000004","document":"wk-form4_1763382643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000102703525000004/wk-form4_1763382643.xml","form_type":"4"}},{"id":997974,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-11-17T12:30:12.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":333333,"price":7.5,"value":2499997.5,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":740546,"source":{"system":"sec-edgar","filing":"0001704317-25-000004","document":"wk-form4_1763382609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431725000004/wk-form4_1763382609.xml","form_type":"4"}},{"id":997973,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-11-17T12:30:12.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":333333,"price":7.5,"value":2499997.5,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1195275,"source":{"system":"sec-edgar","filing":"0001704317-25-000004","document":"wk-form4_1763382609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431725000004/wk-form4_1763382609.xml","form_type":"4"}},{"id":1156316,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:16:02.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000048","document":"wk-form4_1746652555.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000048/wk-form4_1746652555.xml","form_type":"4"}},{"id":1156317,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":37240,"kind":"person","name":"Heffernan Michael Thomas","position":1,"cik":"0001448914","reported_name":"Heffernan Michael Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:15:04.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000046","document":"wk-form4_1746652496.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000046/wk-form4_1746652496.xml","form_type":"4"}},{"id":1156315,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:14:32.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000045","document":"wk-form4_1746652465.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000045/wk-form4_1746652465.xml","form_type":"4"}},{"id":1156314,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:13:54.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000044","document":"wk-form4_1746652427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000044/wk-form4_1746652427.xml","form_type":"4"}},{"id":1156313,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":46857,"kind":"person","name":"GREGORY JULIA P","position":1,"cik":"0001226675","reported_name":"GREGORY JULIA P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:13:14.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000043","document":"wk-form4_1746652387.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000043/wk-form4_1746652387.xml","form_type":"4"}},{"id":1156505,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:12:36.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000042","document":"wk-form4_1746652349.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000042/wk-form4_1746652349.xml","form_type":"4"}},{"id":1156312,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-05-07T21:11:58.000Z","date":"2025-05-05","kind":"grant","planned":false,"acquired":true,"shares":31716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) May 5, 2026 or (b) the date of the 2026 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":31716,"derivative":{"exercise_price":22.62,"expiration_date":"2035-05-05","underlying":"Common Shares","underlying_shares":31716},"source":{"system":"sec-edgar","filing":"0001935979-25-000041","document":"wk-form4_1746652311.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000041/wk-form4_1746652311.xml","form_type":"4"}},{"id":1223902,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":900,"price":30.7261,"value":27653.49,"ownership":{"direct":false,"nature":"By 1994 Charitable Remainder Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":25291,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223901,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":3400,"price":30.7261,"value":104468.74,"ownership":{"direct":false,"nature":"By 2013 Charitable Remainder Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":76570,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223900,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":3400,"price":30.7261,"value":104468.74,"ownership":{"direct":false,"nature":"By 2007 Charitable Remainder Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.54 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":24452,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223899,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T12:01:52.000Z","date":"2025-03-04","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":30.3859,"value":759647.5,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.48, inclusive. The Reporting Person undertakes\nto provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each\nseparate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2320571,"source":{"system":"sec-edgar","filing":"0001935979-25-000018","document":"wk-form4_1741176105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000018/wk-form4_1741176105.xml","form_type":"4"}},{"id":1223898,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-05T11:59:47.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":73170,"price":41,"value":2999970.0,"ownership":{"direct":false,"nature":"By 2013 Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on April 23, 2024 (the \"Original Form 4\"). The Original Form 4 inadvertently misstated that 73,170 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 73,170 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and no Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on April 23, 2024 (the \"Original Form 4\"). The Original Form 4 inadvertently misstated that 73,170 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 73,170 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and no Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust."}],"balance_after":73170,"source":{"system":"sec-edgar","filing":"0001935979-25-000017","document":"wk-form4a_1741175981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597925000017/wk-form4a_1741175981.xml","form_type":"4/A","original_submission_date":"2024-04-23"}},{"id":1308355,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":14250,"derivative":{"underlying":"Common Shares","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308354,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 19,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":19000,"derivative":{"underlying":"Common Shares","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308353,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":112000,"derivative":{"exercise_price":38.64,"expiration_date":"2035-01-05","underlying":"Common Shares","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308352,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2331,"price":38.64,"value":90069.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":4802,"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308351,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:51:26.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7133,"source":{"system":"sec-edgar","filing":"0001935979-25-000006","document":"wk-form4_1736301080.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000006/wk-form4_1736301080.xml","form_type":"4"}},{"id":1308345,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:50:52.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 15,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":11250,"derivative":{"underlying":"Common Shares","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001935979-25-000005","document":"wk-form4_1736301044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000005/wk-form4_1736301044.xml","form_type":"4"}},{"id":1308344,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:50:52.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 15,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":15000,"derivative":{"underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001935979-25-000005","document":"wk-form4_1736301044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000005/wk-form4_1736301044.xml","form_type":"4"}},{"id":1308343,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-08T01:50:52.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":91000,"derivative":{"exercise_price":38.64,"expiration_date":"2035-01-05","underlying":"Common Shares","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001935979-25-000005","document":"wk-form4_1736301044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000005/wk-form4_1736301044.xml","form_type":"4"}},{"id":1308342,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Common Shares","published_at":"2025-01-08T01:50:52.000Z","date":"2025-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1956,"price":38.64,"value":75579.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":97763,"source":{"system":"sec-edgar","filing":"0001935979-25-000005","document":"wk-form4_1736301044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000005/wk-form4_1736301044.xml","form_type":"4"}},{"id":1308341,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63394,"kind":"person","name":"Gentile Kimberly","position":1,"cik":"0001704186","reported_name":"Gentile Kimberly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Clinical Operations"}}],"security":"Common Shares","published_at":"2025-01-08T01:50:52.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99719,"source":{"system":"sec-edgar","filing":"0001935979-25-000005","document":"wk-form4_1736301044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000005/wk-form4_1736301044.xml","form_type":"4"}},{"id":1308350,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:50:01.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 10,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":7500,"derivative":{"underlying":"Common Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001935979-25-000004","document":"wk-form4_1736300995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000004/wk-form4_1736300995.xml","form_type":"4"}},{"id":1308349,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:50:01.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 10,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":10000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001935979-25-000004","document":"wk-form4_1736300995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000004/wk-form4_1736300995.xml","form_type":"4"}},{"id":1308348,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-08T01:50:01.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":38.64,"expiration_date":"2035-01-05","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001935979-25-000004","document":"wk-form4_1736300995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000004/wk-form4_1736300995.xml","form_type":"4"}},{"id":1308347,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:50:01.000Z","date":"2025-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1117,"price":38.64,"value":43160.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 305 shares that were acquired through the Biohaven Employee Share Purchase Plan (the \"ESPP\") on May 31, 2023, 1,336 shares acquired through the ESPP on November 30, 2023, and 742 shares acquired through the ESPP on May 31, 2024."}],"balance_after":65051,"source":{"system":"sec-edgar","filing":"0001935979-25-000004","document":"wk-form4_1736300995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000004/wk-form4_1736300995.xml","form_type":"4"}},{"id":1308346,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63393,"kind":"person","name":"Clark George C.","position":1,"cik":"0001878290","reported_name":"Clark George C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:50:01.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 305 shares that were acquired through the Biohaven Employee Share Purchase Plan (the \"ESPP\") on May 31, 2023, 1,336 shares acquired through the ESPP on November 30, 2023, and 742 shares acquired through the ESPP on May 31, 2024."}],"balance_after":66168,"source":{"system":"sec-edgar","filing":"0001935979-25-000004","document":"wk-form4_1736300995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000004/wk-form4_1736300995.xml","form_type":"4"}},{"id":1308340,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":42750,"derivative":{"underlying":"Common Shares","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308339,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":57000,"derivative":{"underlying":"Common Shares","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308338,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":343000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":343000,"derivative":{"exercise_price":38.64,"expiration_date":"2035-01-05","underlying":"Common Shares","underlying_shares":343000},"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308337,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6805,"price":38.64,"value":262945.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":1796604,"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308336,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1803409,"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1309091,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-07T20:49:17.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":12750,"derivative":{"underlying":"Common Shares","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001935979-25-000003","document":"wk-form4_1736300950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000193597925000003/wk-form4_1736300950.xml","form_type":"4"}},{"id":1309090,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-07T20:49:17.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 17,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":17000,"derivative":{"underlying":"Common Shares","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001935979-25-000003","document":"wk-form4_1736300950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000193597925000003/wk-form4_1736300950.xml","form_type":"4"}},{"id":1309089,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-07T20:49:17.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":104000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":104000,"derivative":{"exercise_price":38.64,"expiration_date":"2035-01-05","underlying":"Common Shares","underlying_shares":104000},"source":{"system":"sec-edgar","filing":"0001935979-25-000003","document":"wk-form4_1736300950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000193597925000003/wk-form4_1736300950.xml","form_type":"4"}},{"id":1309088,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-01-07T20:49:17.000Z","date":"2025-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2561,"price":38.64,"value":98957.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 305 shares that were acquired through the Biohaven Employee Share Purchase Plan (the \"ESPP\") on May 31, 2023, 1,336 shares acquired through the ESPP on November 30, 2023, and 742 shares acquired through the ESPP on May 31, 2024."}],"balance_after":193452,"source":{"system":"sec-edgar","filing":"0001935979-25-000003","document":"wk-form4_1736300950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000193597925000003/wk-form4_1736300950.xml","form_type":"4"}},{"id":1309087,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63643,"kind":"person","name":"Buten Matthew","position":1,"cik":"0001898799","reported_name":"Buten Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-01-07T20:49:17.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance includes 305 shares that were acquired through the Biohaven Employee Share Purchase Plan (the \"ESPP\") on May 31, 2023, 1,336 shares acquired through the ESPP on November 30, 2023, and 742 shares acquired through the ESPP on May 31, 2024."}],"balance_after":196013,"source":{"system":"sec-edgar","filing":"0001935979-25-000003","document":"wk-form4_1736300950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898799/000193597925000003/wk-form4_1736300950.xml","form_type":"4"}},{"id":1320029,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-12-31T12:00:14.000Z","date":"2024-12-30","kind":"purchase","planned":false,"acquired":true,"shares":29000,"price":35.9446,"value":1042393.4,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.57 - $36.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2368741,"source":{"system":"sec-edgar","filing":"0001935979-24-000088","document":"wk-form4_1735646406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597924000088/wk-form4_1735646406.xml","form_type":"4"}},{"id":1392523,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-10-03T11:01:22.000Z","date":"2024-10-02","kind":"purchase","planned":false,"acquired":true,"shares":21052,"price":47.5,"value":999970.0,"ownership":{"direct":false,"nature":"By 2007 Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":21052,"source":{"system":"sec-edgar","filing":"0001935979-24-000078","document":"wk-form4_1727953276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000193597924000078/wk-form4_1727953276.xml","form_type":"4"}},{"id":1392339,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-10-03T11:00:38.000Z","date":"2024-10-02","kind":"purchase","planned":false,"acquired":true,"shares":21052,"price":47.5,"value":999970.0,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":861942,"source":{"system":"sec-edgar","filing":"0001935979-24-000077","document":"wk-form4_1727953231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597924000077/wk-form4_1727953231.xml","form_type":"4"}},{"id":1399558,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-09-25T11:30:20.000Z","date":"2024-09-24","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":44.1932,"value":220966.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.13 - $44.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1620071,"source":{"system":"sec-edgar","filing":"0001935979-24-000075","document":"wk-form4_1727263813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597924000075/wk-form4_1727263813.xml","form_type":"4"}},{"id":1451401,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-07-19T12:56:50.000Z","date":"2024-07-18","kind":"purchase","planned":false,"acquired":true,"shares":28400,"price":35.6684,"value":1012982.56,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.485 - $35.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2339741,"source":{"system":"sec-edgar","filing":"0001562180-24-005805","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024005805/primarydocument.xml","form_type":"4"}},{"id":1473477,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":63392,"kind":"person","name":"Car Bruce","position":1,"cik":"0001798876","reported_name":"Car Bruce","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Shares","published_at":"2024-06-20T11:30:00.000Z","date":"2024-06-17","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":33.583,"value":1007490.0,"ownership":{"direct":false,"nature":"By IRA"},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001562180-24-005174","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024005174/primarydocument.xml","form_type":"4"}},{"id":1497006,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-05-31T13:04:05.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":28000,"price":35.58,"value":996240.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.29 - $35.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2311341,"source":{"system":"sec-edgar","filing":"0001562180-24-004529","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024004529/primarydocument.xml","form_type":"4"}},{"id":1516189,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-05-15T11:31:29.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":34.1918,"value":512877.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.11 - $34.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1615071,"source":{"system":"sec-edgar","filing":"0001562180-24-004045","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024004045/primarydocument.xml","form_type":"4"}},{"id":1517986,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-05-14T11:30:29.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":28500,"price":35.1744,"value":1002470.4,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $35.00 - $35.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":2283341,"source":{"system":"sec-edgar","filing":"0001562180-24-004011","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024004011/primarydocument.xml","form_type":"4"}},{"id":1530696,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50611,"kind":"person","name":"Mehta Kishan","position":1,"cik":"0001850520","reported_name":"Mehta Kishan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:34:01.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003755","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003755/primarydocument.xml","form_type":"4"}},{"id":1530695,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":37240,"kind":"person","name":"Heffernan Michael Thomas","position":1,"cik":"0001448914","reported_name":"Heffernan Michael Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:33:50.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003754","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003754/primarydocument.xml","form_type":"4"}},{"id":1530694,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":46857,"kind":"person","name":"GREGORY JULIA P","position":1,"cik":"0001226675","reported_name":"GREGORY JULIA P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:33:35.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003753","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003753/primarydocument.xml","form_type":"4"}},{"id":1530693,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":16186,"kind":"person","name":"HUGIN ROBERT J","position":1,"cik":"0001232505","reported_name":"HUGIN ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:33:21.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003752","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003752/primarydocument.xml","form_type":"4"}},{"id":1530692,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":50610,"kind":"person","name":"Antonijevic Irina","position":1,"cik":"0001926476","reported_name":"Antonijevic Irina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:33:08.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003751","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003751/primarydocument.xml","form_type":"4"}},{"id":1530932,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:32:56.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003750","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003750/primarydocument.xml","form_type":"4"}},{"id":1530691,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-02T23:32:43.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":16592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option will vest in full on the earlier of (a) April 30, 2025 or (b) the date of the 2025 Annual Meeting of Shareholders, in each case subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":16592,"derivative":{"exercise_price":38.8,"expiration_date":"2034-04-30","underlying":"Common Shares","underlying_shares":16592},"source":{"system":"sec-edgar","filing":"0001562180-24-003749","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003749/primarydocument.xml","form_type":"4"}},{"id":1535535,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-25T11:32:14.000Z","date":"2024-04-24","kind":"purchase","planned":false,"acquired":true,"shares":25503,"price":39.1785,"value":999169.2855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.13 - $39.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1600071,"source":{"system":"sec-edgar","filing":"0001562180-24-003521","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003521/primarydocument.xml","form_type":"4"}},{"id":1536970,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":36340,"kind":"person","name":"Bailey Gregory","position":1,"cik":"0001329505","reported_name":"Bailey Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-23T11:54:35.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":48780,"price":41,"value":1999980.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":1574568,"source":{"system":"sec-edgar","filing":"0001562180-24-003495","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003495/primarydocument.xml","form_type":"4"}},{"id":1537056,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-23T11:54:20.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":73170,"price":41,"value":2999970.0,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":2254841,"source":{"system":"sec-edgar","filing":"0001562180-24-003494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003494/primarydocument.xml","form_type":"4"}},{"id":1537055,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-23T11:54:20.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":97560,"price":41,"value":3999960.0,"ownership":{"direct":false,"nature":"By 2021 B-H Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":4096512,"source":{"system":"sec-edgar","filing":"0001562180-24-003494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003494/primarydocument.xml","form_type":"4"}},{"id":1537054,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-23T11:54:20.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":24391,"price":41,"value":1000031.0,"ownership":{"direct":false,"nature":"By 1994 Charitable Remainder Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":24391,"source":{"system":"sec-edgar","filing":"0001562180-24-003494","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003494/primarydocument.xml","form_type":"4"}},{"id":1536969,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-23T11:54:02.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":121951,"price":41,"value":4999991.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":1788417,"source":{"system":"sec-edgar","filing":"0001562180-24-003493","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003493/primarydocument.xml","form_type":"4"}},{"id":1547138,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-04-06T00:21:33.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":2091,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, 48,505 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3. The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 2,091 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, 48,505 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3. The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 2,091 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":2181671,"source":{"system":"sec-edgar","filing":"0001562180-24-003337","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024003337/primarydocument.xml","form_type":"4"}},{"id":1546936,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-06T00:21:14.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":231,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":407213,"source":{"system":"sec-edgar","filing":"0001562180-24-003336","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003336/primarydocument.xml","form_type":"4"}},{"id":1546935,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-06T00:21:14.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":231,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":840890,"source":{"system":"sec-edgar","filing":"0001562180-24-003336","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003336/primarydocument.xml","form_type":"4"}},{"id":1546934,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-06T00:21:14.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":1666466,"source":{"system":"sec-edgar","filing":"0001562180-24-003336","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003336/primarydocument.xml","form_type":"4"}},{"id":1587676,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":23486,"kind":"person","name":"CHILDS JOHN W","position":1,"cik":"0001027035","reported_name":"CHILDS JOHN W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2024-03-08T23:35:38.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":19412,"ownership":{"direct":false,"nature":"By John W Childs 2013 Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":2179580,"source":{"system":"sec-edgar","filing":"0001562180-24-002510","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1027035/000156218024002510/primarydocument.xml","form_type":"4"}}],"next_cursor":"2024-03-08T23:35:38.000000Z,1587676"}